Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosilate versus propofol with remifentanil in laparoscopic surgery anesthesia
ChiCTR2100042461Phase 4Recruiting
- Sponsor
- Sun Yat-sen University Third Affiliated Hospital Yuedong Hospital
- Start
- Nov 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam, propofol and remifentanil (3 arms), sponsored by Sun Yat-sen University Third Affiliated Hospital Yuedong Hospital. Primary endpoints: Systolic blood pressure, Diastolic blood pressure and 6 more. Started Nov 2020; status: recruiting.
02
Drugs
remimazolampropofolremifentanil
Beyond the preview
Go deeper on ChiCTR2100042461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042461.